Intestinal P‐glycoprotein inhibitors, benzoxanthone analogues

E-ISSN： 2042-7158|70|2|234-241

ISSN： 0022-3573

Source： JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol.70, Iss.2, 2018-02, pp. : 234-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of Multidrug Resistance in Cancer Cells by Inhibitors of P-Glycoprotein

By Safa Ahmad R.

CHIMIA International Journal for Chemistry, Vol. 53, Iss. 6, 1999-06 ,pp. : 299-299

Swiss Chemical Society

Access to resources Recommend Favorite

Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors

By König Gerhard

Monatshefte für Chemie / Chemical Monthly, Vol. 139, Iss. 4, 2008-04 ,pp. : 401-405

Springer Publishing Company

Access to resources Recommend Favorite

Design of Fexofenadine Prodrugs Based on Tissue‐Specific Esterase Activity and Their Dissimilar Recognition by P‐Glycoprotein

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 3076-3083

John Wiley & Sons Inc

Access to resources Recommend Favorite

Arylamino Esters As P‐Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity

CHEMMEDCHEM, Vol. 10, Iss. 8, 2015-08 ,pp. : 1339-1343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple Linear Regression Analysis Indicates Association of P‐Glycoprotein Substrate or Inhibitor Character with Bitterness Intensity, Measured with a Sensor

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 2789-2794

John Wiley & Sons Inc

Access to resources Recommend Favorite